or
www.spandidos-publications.com
Home  | About  | Contact
Spandidos Logo
Advanced Search
Login  | Register


congress_banner

main_table_top_image
   Current Issue Early Online Archive Manuscript Submission About Editor and Editorial Board Sitemap
Promotion of melanoma growth by the metabolic hormone leptin

Authors:
Julie A. Ellerhorst, A. H. Diwan, Shyam M. Dang, Deon G. Uffort, Marilyn K. Johnson, Carolyn P. Cooke, Elizabeth A. Grimm

Affiliations:
Department of Experimental Therapeutics, Unit 362, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA. jaellerh@mdanderson.org

Doi:
10.3892/or_00000713

Pages:
901-907

Abstract:

We have previously shown that melanoma cells proliferate in response to the metabolic hormones TRH and TSH. The objective of the present study was to test the hypothesis that a third metabolic hormone, leptin, serves as a growth factor for melanoma. Using western blotting, indirect immunofluorescence, and RT-PCR, leptin receptors were found to be expressed by human melanoma cells. In contrast, cultured melanocytes expressed message for the receptor without detectable protein. Melanoma cells responded to treatment with leptin by activating the MAPK pathway and proliferating. Melanoma cells but not melanocytes, also expressed leptin protein, creating a potential autocrine loop. Examination of human melanoma tumors by immunohistochemistry revealed that melanomas and nevi expressed leptin at a high frequency. Melanomas also strongly expressed the leptin receptor, whereas nevi expressed this receptor to a much lesser degree. We conclude that leptin is a melanoma growth factor and that a leptin autocrine-loop may contribute to the uncontrolled proliferation of these cells.

Oncology Reports

April 2010
Volume 23 Number 4


Viewing options: Sign up for eToc alerts

Share this article:



main_table_bottom_image